The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Bausch Health Partners with YUN
Pharma & Human Health

Bausch Health Partners with YUN

JUN 24, 2025
EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
Editor's Choice

EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum

JUN 23, 2025
Diagnostic and therapeutic use of the microbiota will become reality within the next 5-10 years
Pharma & Human Health

Diagnostic and therapeutic use of the microbiota will become reality within the next 5-10 years

JUN 23, 2025
32 Biosciences receives $6 million in funding to advance gut microbiome platform technologies
Finance

32 Biosciences receives $6 million in funding to advance gut microbiome platform technologies

JUN 11, 2025
MaaT Pharma Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg®
Finance

MaaT Pharma Submits Marketing Authorization Application to the European Medicines Agency (EMA) for Xervyteg®

JUN 3, 2025
DynaMAP – Precision Metagenomics beyond Sequencing
Editor's Choice

DynaMAP – Precision Metagenomics beyond Sequencing

MAY 27, 2025
The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
Editor's Choice

The Selection of a Pre-Clinical Model is Driven by the Specific Research Question

MAY 13, 2025
A symbiotic gut fungus wards off liver disease in mice
Pharma & Human Health

A symbiotic gut fungus wards off liver disease in mice

MAY 7, 2025
Study of facial bacteria could lead to probiotics that promote healthy skin
Biotics and Supplements

Study of facial bacteria could lead to probiotics that promote healthy skin

MAY 7, 2025
No more copy-pasting: DNA base editing for better Lactobacillus strains
Pharma & Human Health

No more copy-pasting: DNA base editing for better Lactobacillus strains

APR 29, 2025
Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
Finance

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

APR 29, 2025